Abbott Laboratories

NYS : ABT
Pharmaceuticals
Abbott Park IL
2013 Revenue (US$ Millions)$21,848
2012 Revenue (US$ Millions)$39,874
Revenue Growth (%)-45.21%
Net Income (US$ Millions)$2,576
Common Shares Outstanding (Millions)$1,548
Earnings Per Share (US$)$1.62
Price To Earnings Ratio65.5
Total Equity (US$ Millions)$25,171
Profit Margin (%)11.79%
Return On Equity (%)9.64%
Long Term Debt (US$ Millions)$3,388
Debt To Equity Ratio (%)0.13%
Market Capitalization (US$ Millions)$59,339
Total Assets (US$ Millions)$42,953
Return on Assets (%)3.83
Current Assets (US$ Millions)$19,247
Inventories (US$ Millions)$2,693
Current Liabilities (US$ Millions)$9,507
Cost of Goods Sold (US$ Millions)$10,040
Asset Turnover0.51
Inventory Turnover3.1
ExchangeNYS